The Valley Desk

ReviewDiabetes, obesity & metabolismPublished

Assessing the benefit-risk profile of newer glucose-lowering drugs: A systematic review and network meta-analysis of randomized outcome trials

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Penn Medicine, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
Diabetes, obesity & metabolism
Published
Subject terms
Humans; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Blood Glucose; Hypoglycemic Agents; Risk Assessment; Randomized Controlled Trials as Topic; Dipeptidyl-Peptidase IV Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Glucagon-Like Peptide-1 Receptor Agonists; Type 2 diabetes; Sglt2 Inhibitor
PubMed ID
39723481
PubMed Central ID
PMC12135018
Added to directory
Source checked

Report a correction or request removal